THERAVECTYS has refined a technology platform for modulating the immune response through gene transfer into dendritic cells, the key antigen-presenting cells of the immune system. The THERAVECTYS platform exploits lentiviral gene vectors designed to achieve highly efficient gene transfer.

The THERAVECTYS platform has been optimized for flexibility with respect to antigens, and hence can be applied across a broad range of diseases